Development of a Couple-based Mindfulness Intervention for Chronic Pain
Preliminary Test of an Integrative Intervention to Alleviate Chronic Pain and Improve Quality of Life
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Michigan
-
Detroit, Michigan, Stati Uniti, 48202
- Wayne State University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- At least one spouse with some pain interference.
- Relationship dissatisfaction.
- Both partners at least 21 years old.
- Couples must also be married or cohabitating for at least 2 years regardless of sexual orientation to participate in the study.
Exclusion Criteria:
- Current suicidal or homicidal ideation or intent
- Current psychotic symptoms
- Cognitive impairment
- Malignancies (e.g., cancer) in either partner
- Current domestic violence
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Therapy
Mindfulness and Acceptance Therapy
|
Couples will learn psychological flexibility skills including mindfulness, acceptance, and values-based action as well as relational flexibility skills including empathic listening and responding during weekly 1.5-hour long sessions over the course of this 6-week intervention.
|
|
Comparatore attivo: Education
Health Education
|
Couples will learn about chronic pain including causes, consequences, and how to talk with their health care professionals about their pain during weekly 1.5-hour long sessions over the course of this 6-week program.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Depressive Symptoms from Baseline to 1-month Followup
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Beck Depression Inventory-II
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Pain Intensity
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Visual Rating Scale, Multidimensional Pain Inventory, Brief Pain Inventory
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Pain Quality
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
McGill Pain Questionnaire
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Quality of Life
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Satisfaction with Life Scale
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Relationship Satisfaction
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Dyadic Adjustment Scale; Dyadic Adjustment Scale-7
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Sleep Quality
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
PROMIS Sleep Disturbance and Sleep-related Impairment Scales
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Perceived Improvement
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Patient Global Impression of Change
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Acceptance of Chronic Pain
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Chronic Pain Acceptance Questionnaire (baseline, post-treatment, followup); Chronic Pain Acceptance Chronic Pain Acceptance Questionnaire
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Anxiety and Catastrophizing about Pain
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Pain Anxiety Symptoms Scale, Pain Catastrophizing Scale (baseline, post-treatment, followup); Pain Catastrophizing Scale-Shortened Version (weekly)
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Mindfulness
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Five Facet Mindfulness Scale
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Values-Based Action
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Chronic Pain Values Inventory
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Dispositional Empathy
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Interpersonal Reactivity Index
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Emotional Expression
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Ambivalence Over Emotional Expression Questionnaire, Holding Back Scale
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Emotional Validation and Invalidation
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Coded from Couple Discussion Task
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
|
Change in Partner-perceived Empathy
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Perceived Partner Responsiveness Scale
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Treatment Credibility
Lasso di tempo: Baseline
|
Credibility of Treatment Scale
|
Baseline
|
|
Therapist Adherence
Lasso di tempo: Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
audio recordings of sessions
|
Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
|
Therapy Homework Compliance
Lasso di tempo: Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
Homework Rating Scale and time spend completing homework
|
Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
|
Therapy Session Satisfaction
Lasso di tempo: Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
Participants' satisfaction with session
|
Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
|
Intent to Complete Therapy Homework
Lasso di tempo: Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
Participants' intention to complete homework
|
Participants will be followed for the duration of the intervention, an expected average of 6 weeks
|
|
Adverse Events
Lasso di tempo: Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Adverse event data will be collected and reported
|
Participants will be followed for the duration of the intervention and followup period, an expected average of 10 weeks
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Investigatore principale: Annmarie Cano, Ph.D., Wayne State University
Studiare le date dei record
Studia le date principali
Inizio studio
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- 1R21AT007939-01A1 (Sovvenzione/contratto NIH degli Stati Uniti)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .